Prescription only · clinician reviewed
Tesamorelin Injectable
A growth hormone-releasing analog with clinician oversight and follow-up.
Member pricing via Chiro Peptides NY
- Billed every 28 days
- Clinician review and care-team messaging included
- We'll bill this supply again when it's due. Complete the portal follow-up so the next fill can ship. You may still have medication on hand.
- Cancel anytime in your patient portal
Free eligibility check · $0 today · You are charged only if a clinician prescribes
Choosing a plan starts an intake, not an order. A licensed clinician reviews it and decides whether to prescribe — they may decline, and you are not charged unless they approve.
Tesamorelin Injectable
A growth hormone-releasing analog with clinician oversight and follow-up.
- Visceral fat
- Clinician reviewed
- A studied target
Why people ask about it
What this is for
A specific, studied target
Unlike broad wellness peptides, tesamorelin has a defined indication and clinical trial data behind it in that population.
Visceral fat, not just scale weight
The studied effect concerns deeper abdominal fat around the organs, which is the fat depot most associated with metabolic risk.
Works through your own release
It prompts your pituitary rather than supplying growth hormone directly, so your feedback loops remain involved.
Reported experience, not established outcomes. Nothing here is a promise of a result or of a prescription.
Before you start
What to know about Tesamorelin Injectable
Tesamorelin is a growth hormone-releasing hormone analog. Its established, FDA-approved use is reducing excess visceral abdominal fat in adults with HIV-associated lipodystrophy. Any other use is off-label and decided by your clinician.
- 01
Tesamorelin is FDA-approved for one specific thing: reducing excess visceral abdominal fat in adults with HIV-associated lipodystrophy.
- 02
It is the best-evidenced compound in this category — it has Phase 3 trial data, which most wellness peptides do not.
- 03
That evidence was generated in a particular population. Using it outside that indication is off-label, and the data does not transfer automatically.
- 04
Prescription only, and your clinician may decline.
Who this tends to fit
- You are interested in visceral fat specifically
- You want a clinician's honest read on whether it applies to you
- You accept that use outside the approved indication is off-label
- You want to be reassessed rather than left on treatment
Fitting the description does not mean you will be prescribed this. A clinician decides after reviewing your intake.
Tesamorelin is FDA-approved specifically for HIV-associated lipodystrophy. Use outside that indication is off-label, and the evidence supporting it in other groups is limited. A compounded formulation is not an FDA-approved product. Your clinician decides whether it is appropriate for you.
The science
The science of Tesamorelin Injectable
Tap a card for what the literature actually examines. Most of it is preclinical, and none of it is a reason to expect a result.
How care works
What clinician oversight means here
Telehealth varies a lot in how much of this is real. Here is exactly what is and is not true of ours.
A licensed clinician decides
Your intake is reviewed by a clinician licensed in your state. They choose the treatment and the dose, and they can decline. Insert MD does not make that call.
Dispensed by a licensed pharmacy
Nothing ships without a prescription. Your order is prepared and sent by a licensed pharmacy, not packed by us.
Reviewed again at follow-up
Continuing is a decision, not a default. Your clinician reassesses whether the treatment still fits before you carry on.
Compounded is not FDA-approved
Several treatments here are compounded. The FDA does not review compounded medications for safety, effectiveness, or quality, and we say so on every page where it applies.
How it works
Three steps, no charge to find out
Check eligibility
A quick questionnaire — takes about 2 minutes. No charge to see if you qualify.
Provider review
A licensed clinician reviews your intake and approves an appropriate plan.
Delivered to you
Your treatment ships discreetly, directly to your door, with care-team support.
Precise, consistent dosing
Your prescription is prepared by a licensed pharmacy and reviewed by a clinician licensed in your state. Nothing ships until they approve.
- Compounded by a licensed pharmacy
- Identity, potency, and purity tested
- Dose set by a licensed clinician
- Ships ready to use — no home mixing
Good to know
Tesamorelin binds the same receptor as your natural growth hormone-releasing hormone, prompting your pituitary to release growth hormone. In its studied population, that shift was associated with reduced visceral fat, the deeper abdominal fat that sits around the organs.
Tesamorelin is FDA-approved specifically for HIV-associated lipodystrophy. Use outside that indication is off-label, and the evidence supporting it in other groups is limited. A compounded formulation is not an FDA-approved product. Your clinician decides whether it is appropriate for you.
- Pregnant or breastfeeding
- Active or previous malignancy
- Existing head trauma
- Uncontrolled diabetes
- Current lower extremity edema
Your dose, schedule, and how long you stay on treatment are set by the prescribing clinician after reviewing your intake, and may differ from any general description here. General information, not medical advice.
No. Its approved use is HIV-associated lipodystrophy. Anything else is off-label and a clinical judgement your clinician makes, and they may decline.
Both act on the growth hormone-releasing hormone pathway, but tesamorelin is a distinct analog with its own approved indication and trial data. Your clinician can explain which, if either, fits you.
A licensed clinician does, after reviewing your intake. Nothing on this page is a prescription or a promise of one, and your plan may look different from any general description here.
References
Scientific sources
Primary papers for readers who want them. Most of this literature is preclinical — it is not a sales argument, and it is not a reason to expect a result.
- 1.Falutz J, Allas S, Blot K, et al. Metabolic effects of a growth hormone-releasing factor in patients with HIV. N Engl J Med. 2007;357(23):2359-70.
- 2.Falutz J, Mamputu JC, Potvin D, et al. Effects of tesamorelin (TH9507), a growth hormone-releasing factor analogue, in human immunodeficiency virus-infected patients with excess abdominal fat: a pooled analysis of two multicenter, double-blind placebo-controlled phase 3 trials with safety extension data. J Clin Endocrinol Metab. 2010;95(9):4291-304.
- 3.Falutz J, Potvin D, Mamputu JC, et al. Effects of tesamorelin, a growth hormone-releasing factor, in HIV-infected patients with abdominal fat accumulation: a randomized placebo-controlled trial with a safety extension. J Acquir Immune Defic Syndr. 2010;53(3):311-22.
- 4.Stanley TL, Fourman LT, Feldpausch MN, et al. Effects of tesamorelin on non-alcoholic fatty liver disease in HIV: a randomised, double-blind, multicentre trial. Lancet HIV. 2019;6(12):e821-30.
- 5.Baker LD, Barsness SM, Borson S, et al. Effects of growth hormone-releasing hormone on cognitive function in adults with mild cognitive impairment and healthy older adults: results of a controlled trial. Arch Neurol. 2012;69(11):1420-9.
- 6.Stanley TL, Falutz J, Marsolais C, et al. Reduction in visceral adiposity is associated with an improved metabolic profile in HIV-infected patients receiving tesamorelin. Clin Infect Dis. 2012;54(11):1642-51.
Plain language
Terms you might hear
- Peptide
- A short chain of amino acids. Most act as signals between cells.
- Pituitary gland
- A gland at the base of the brain that releases growth hormone and several other hormones on the brain's instruction.
- GHRH
- Growth hormone-releasing hormone — the natural signal that tells the pituitary to release growth hormone.
- IGF-1
- Insulin-like growth factor 1. Made largely by the liver in response to growth hormone, and the blood marker clinicians usually track.
- Pulsatile release
- Hormone released in bursts rather than a steady stream. Growth hormone normally pulses, with the largest burst during deep sleep.
- Visceral fat
- Deeper abdominal fat that sits around the organs, as opposed to the fat just under the skin.
- Compounded
- Prepared for an individual patient by a licensed pharmacy. Compounded medications are not FDA-approved.
- Off-label
- Prescribing an approved drug for a purpose outside its approved indication. Legal, common, and a clinical judgement your prescriber makes.
Ready when you are
See if Tesamorelin Injectable is right for you
A licensed clinician reviews your intake and decides. You are not charged unless they approve.
Tesamorelin Injectable
$88.00 · $0 today